United States · 
Who invested in Sling Therapeutics?
Sling Therapeutics's investors include TPG and Forbion Capital Partners.
United States · Series C startup
Who invested in Sling Therapeutics
Funding summaryUpdated 26 Oct 2026
$123Mraised across 1 round since 2026, from 1 source
- Latest round
- Series C, $123MSept 2026
- Investors
- 2
The rounds
- Sept 2026
Founders and team
From Sling Therapeutics's own website: 2 on the team.
- Catherine RadovichSenior Vice President, Clinical Operations
- Manage ConsentSenior Vice President, Head of Development Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sling Therapeutics
How much has Sling Therapeutics raised?
Sling Therapeutics has raised $123M across 1 round since 2026.
When did Sling Therapeutics last raise?
Sling Therapeutics's most recent round was a Series C of $123M in Sept 2026.
What was Sling Therapeutics's biggest round?
Its most recent round, $123M in Sept 2026, is also its largest on record.
Who backed Sling Therapeutics first?
Sling Therapeutics's first round on record, in Sept 2026, was backed by TPG and Forbion Capital Partners.
What stage is Sling Therapeutics at?
Sling Therapeutics's latest named round is a Series C, in Sept 2026.
Where is Sling Therapeutics based?
Sling Therapeutics is based in the United States.
Companies like Sling Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.